Life Technologies | GenomeWeb

Life Technologies

The case is being framed as either upholding a strong patent regime or dealing a blow to US-based manufacturing as part of the global supply chain.

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.

Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.

This Week in PNAS

In PNAS this week: common variants that influence viral load in HIV patients, tumor evolution patterns, and more.

Experts at Vanderbilt discussed future expansion of its PREDICT program, and provided a glimpse at how doctors have responded to genomic information in EMRs.

Acquisitions in the past few years have enriched Thermo Fisher's portfolio of PCR platforms, but the firm says the PikoReal is not being developed for IVD use.

The technology is used to regulate temperature across a PCR plate.

The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.

After further validation, Thermo Fisher commercially launched a CE-IVD version of the same panel last month.

An increasing number of publications using droplet-based digital PCR platforms suggests acceptance and uptake of the technology.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.